NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 168 filers reported holding NOVOCURE LTD in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,578,840 | -74.7% | 221,600 | -35.1% | 0.00% | -70.0% |
| Q2 2023 | $14,163,950 | -37.0% | 341,300 | -8.7% | 0.01% | -33.3% |
| Q1 2023 | $22,486,346 | -20.0% | 373,900 | -2.4% | 0.02% | -25.0% |
| Q4 2022 | $28,100,385 | -9.1% | 383,100 | -5.9% | 0.02% | -9.1% |
| Q3 2022 | $30,928,000 | +9.2% | 407,048 | -0.1% | 0.02% | +15.8% |
| Q2 2022 | $28,311,000 | -15.6% | 407,348 | +0.6% | 0.02% | 0.0% |
| Q1 2022 | $33,533,000 | +26.0% | 404,748 | +14.2% | 0.02% | +18.8% |
| Q4 2021 | $26,612,000 | -37.8% | 354,448 | -3.7% | 0.02% | -40.7% |
| Q3 2021 | $42,756,000 | -48.7% | 368,048 | -2.1% | 0.03% | -47.1% |
| Q2 2021 | $83,371,000 | +89.5% | 375,848 | +12.9% | 0.05% | +75.9% |
| Q1 2021 | $43,990,000 | -21.7% | 332,800 | +2.6% | 0.03% | -27.5% |
| Q4 2020 | $56,151,000 | +160.7% | 324,500 | +67.7% | 0.04% | +135.3% |
| Q3 2020 | $21,538,000 | +92.1% | 193,500 | +2.3% | 0.02% | +88.9% |
| Q2 2020 | $11,214,000 | +8.4% | 189,100 | +23.1% | 0.01% | -18.2% |
| Q1 2020 | $10,343,000 | -18.4% | 153,600 | +2.1% | 0.01% | -15.4% |
| Q4 2019 | $12,674,000 | +17.5% | 150,400 | +4.3% | 0.01% | +18.2% |
| Q3 2019 | $10,783,000 | +20.6% | 144,200 | +2.0% | 0.01% | +10.0% |
| Q2 2019 | $8,941,000 | +56.4% | 141,400 | +19.1% | 0.01% | +66.7% |
| Q1 2019 | $5,718,000 | +49.2% | 118,700 | +3.7% | 0.01% | +20.0% |
| Q4 2018 | $3,833,000 | -33.2% | 114,500 | +4.6% | 0.01% | -16.7% |
| Q3 2018 | $5,738,000 | +67.4% | 109,500 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $3,427,000 | +103.1% | 109,500 | +41.5% | 0.00% | +100.0% |
| Q1 2018 | $1,687,000 | +13.3% | 77,400 | +5.0% | 0.00% | 0.0% |
| Q4 2017 | $1,489,000 | +1.8% | 73,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,463,000 | +19.9% | 73,700 | +4.5% | 0.00% | +100.0% |
| Q2 2017 | $1,220,000 | +113.7% | 70,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $571,000 | +3.3% | 70,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $553,000 | -8.1% | 70,500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $602,000 | -26.9% | 70,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $823,000 | – | 70,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |